Serum 25-hydroxy vitamin D and prostate cancer risk in a large nested case-control study.
about
Do studies reporting 'U'-shaped serum 25-hydroxyvitamin D-health outcome relationships reflect adverse effects?The Use of 1α,25-Dihydroxyvitamin D₃ as an Anticancer AgentVitamin D and Colorectal, Breast, and Prostate Cancers: A Review of the Epidemiological EvidenceVitamin D and Immune Response: Implications for Prostate Cancer in African AmericansLifestyle and dietary factors in the prevention of lethal prostate cancerCirculating vitamin D, vitamin D-related genetic variation, and risk of fatal prostate cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.Vitamin D and extra-skeletal health: causality or consequencePlasma vitamin D and prostate cancer risk: results from the Selenium and Vitamin E Cancer Prevention Trial.Applying the precautionary principle to nutrition and cancer.Associations of circulating 25-hydroxyvitamin D with prostate cancer diagnosis, stage and gradeProspective study of ultraviolet radiation exposure and risk of cancer in the United StatesVitamin D transport proteins megalin and disabled-2 are expressed in prostate and colon epithelial cells and are induced and activated by all-trans-retinoic acidA phase I study to determine the maximum tolerated dose and safety of oral LR-103 (1α,24(S)Dihydroxyvitamin D2) in patients with advanced cancer.Association between Plasma 25-Hydroxyvitamin D, Ancestry and Aggressive Prostate Cancer among African Americans and European Americans in PCaPBoth serum 25-hydroxyvitamin D and calcium levels may increase the risk of incident prostate cancer in Caribbean men of African ancestry.Vitamin D and Cancer: Diversity, Complexity, and Still a Ways to GoRisk of prostate cancer in African-American men: Evidence of mixed effects of dietary quercetin by serum vitamin D status.Long Term Association between Serum 25-Hydroxyvitamin D and Mortality in a Cohort of 4379 MenDietary supplements and cancer prevention: balancing potential benefits against proven harms.Race and BMI modify associations of calcium and vitamin D intake with prostate cancerPlasma 25-hydroxyvitamin D(3) and bladder cancer risk according to tumor stage and FGFR3 status: a mechanism-based epidemiological study.Circulating 25-hydroxyvitamin D, vitamin D-binding protein and risk of prostate cancerGenetic variation in the vitamin d pathway in relation to risk of prostate cancer--results from the breast and prostate cancer cohort consortium.Circulating 25-Hydroxyvitamin D and Prostate Cancer Survival.Pigmentation-related phenotypes and risk of prostate cancer.Association between Serum 25-Hydroxy-Vitamin D and Aggressive Prostate Cancer in African American Men.Vitamin D-binding protein, circulating vitamin D and risk of renal cell carcinoma.Interactions of the Insulin-Like Growth Factor Axis and Vitamin D in Prostate Cancer Risk in the Prostate Cancer Prevention Trial.Interactions Between Genome-Wide Significant Genetic Variants and Circulating Concentrations of 25-Hydroxyvitamin D in Relation to Prostate Cancer Risk in the National Cancer Institute BPC3.Overview of Dietary Supplements in Prostate Cancer.Plasma 25-hydroxy vitamin D and subsequent prostate cancer risk in a nested Case-Control study in Japan: The JPHC study.Vitamins, metabolomics, and prostate cancer.Metabolomics analysis of serum 25-hydroxy-vitamin D in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study.Vitamin D, PTH, and calcium in relation to survival following prostate cancer.A prospective study of plasma 25-hydroxyvitamin D concentration and prostate cancer risk.Serum 25-hydroxyvitamin D concentrations and risk of prostate cancer: results from the Prostate Cancer Prevention Trial.Predicting vitamin D deficiency in older Australian adults.Circulating vitamin D concentration and risk of seven cancers: Mendelian randomisation study.Can vitamin D supplementation reduce prostate cancer disparities?Circulating vitamin D concentration and risk of prostate cancer: a dose-response meta-analysis of prospective studies.
P2860
Q26739511-A6C88119-5F6B-4DFF-9A2C-9A99743D255CQ26749030-5B4D8D54-D09D-4763-978A-AD8AC301EB7EQ26766256-D57A3066-767F-4067-9B0A-4AFC9443D3EFQ26768536-1C1F6431-FB72-47E1-A013-4D7C169CE184Q27025735-C25CE9C3-693B-4216-9BE4-8B6048C69E9DQ27336054-35F06175-E111-4454-9495-536D37166EB2Q28066698-715CC8B4-9706-4D17-A271-076FEDE8A919Q33992150-D533196D-A660-491B-9B4E-35FA186BAD45Q34041094-1AF71A38-52A7-4AE8-BBF9-7EC9C0A54A46Q34228158-689DD411-3AC8-45A5-BFE6-45716C4D00CBQ34271258-512BA6FE-38BA-4A6A-B524-29148E463CB7Q34541761-F96B8D84-4DF0-4794-99D8-7E502385AE1DQ34799393-86AE6BD5-46CE-466C-9CF4-42969106D45CQ35546959-3FED5C9D-01AE-471F-904B-F3FA4D8C573EQ35755412-7104324C-FE1B-443F-AF2A-596AFB7967B2Q35925081-818A9696-C4B7-486F-A5E7-78FE3A43C307Q35952018-BF291B00-7202-4BA6-9285-8DFB569ED310Q35961214-DE09C3F0-705D-4E65-ADE1-5E00A4F93BBDQ35962084-F7FC8626-6917-4D9E-A5FA-F9B506B69C24Q36254438-1BAAE212-07AC-4BE1-9EAA-A97BBD90D00BQ36476562-CACFAC09-E891-4933-B575-529390A4D0BFQ36674846-1ADC46B1-4E20-456A-B48A-F594994AAE3EQ36741744-21EC24A6-FA48-471A-A3BB-05D901E99CDAQ36917872-43BED36B-7EC1-408A-9DDD-2DCF68304CE5Q37081867-68203484-8175-40B9-BDCF-FFDD04780752Q37628321-52182E46-B019-4665-AC5C-B0DA3829B5CBQ37649866-7E5976A7-D6A0-40DB-BB08-45A315357657Q38832987-64DA2819-3A6D-48A2-9816-E3F9A7ABB3D7Q38842066-6159408C-2173-49E2-B996-B9B477580957Q38950685-29ABBFF9-B220-4D27-A667-ACA48BB587F8Q39272197-3E940FBB-BC0F-49F2-973A-557760ADA4EFQ39658509-35BA3EC6-B0E4-47F9-A677-63C2D1957575Q40622136-6832A8E0-3D31-4B02-AAFD-5198BEF6A11BQ40829133-D525B4A8-AF1F-4C5D-80C9-8691463D445CQ41122869-9810D4C4-CFCE-44C6-9295-B4FD28CDC2EBQ42766017-34FF0907-FF0B-4198-AAB5-9D6FC7D9D544Q44022876-24E5E1BA-98C6-4D59-B55E-5C15CBA08E58Q45071502-52A1D98A-DB45-49D7-9D28-1D0C9B811C78Q46658342-F836B2E7-39D9-4061-B183-EC0EB80F406CQ49540308-62F54870-D487-4870-9088-4B5B1F67AC1D
P2860
Serum 25-hydroxy vitamin D and prostate cancer risk in a large nested case-control study.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Serum 25-hydroxy vitamin D and prostate cancer risk in a large nested case-control study.
@ast
Serum 25-hydroxy vitamin D and prostate cancer risk in a large nested case-control study.
@en
type
label
Serum 25-hydroxy vitamin D and prostate cancer risk in a large nested case-control study.
@ast
Serum 25-hydroxy vitamin D and prostate cancer risk in a large nested case-control study.
@en
prefLabel
Serum 25-hydroxy vitamin D and prostate cancer risk in a large nested case-control study.
@ast
Serum 25-hydroxy vitamin D and prostate cancer risk in a large nested case-control study.
@en
P2093
P2860
P50
P1476
Serum 25-hydroxy vitamin D and prostate cancer risk in a large nested case-control study.
@en
P2093
Dominick Parisi
Ronald L Horst
Stephanie J Weinstein
P2860
P304
P356
10.1158/1055-9965.EPI-11-0403
P577
2011-07-22T00:00:00Z